Ueno T - Search Results

1

Pertuzumab retreatment for HER2-positive advanced breast cancer: A randomized, open-label phase III study (PRECIOUS).

Yamamoto Y, Iwata H, Taira N, Masuda N, Takahashi M, Yoshinami T, Ueno T, Toyama T, Yamanaka T, Takano T, Kashiwaba M, Tsugawa K, Hasegawa Y, Tamura K, Tada H, Hara F, Fujisawa T, Niikura N, Saji S, Morita S, Toi M, Ohno S. Yamamoto Y, et al. Among authors: ueno t. Cancer Sci. 2022 Sep;113(9):3169-3179. doi: 10.1111/cas.15474. Epub 2022 Jul 23. Cancer Sci. 2022. PMID: 35754298 Free PMC article. Clinical Trial.

2

A close association between alteration in growth kinetics by neoadjuvant chemotherapy and survival outcome in primary breast cancer.

Takada M, Kataoka A, Toi M, Bando H, Toyama K, Horiguchi S, Ueno T, Linder S, Saji S, Hayashi Y, Funata N, Kinoshita J, Murakami S, Ohono S. Takada M, et al. Among authors: ueno t. Int J Oncol. 2004 Aug;25(2):397-405. Int J Oncol. 2004. PMID: 15254737

3

Cytokeratin-18 is a useful serum biomarker for early determination of response of breast carcinomas to chemotherapy.

Olofsson MH, Ueno T, Pan Y, Xu R, Cai F, van der Kuip H, Muerdter TE, Sonnenberg M, Aulitzky WE, Schwarz S, Andersson E, Shoshan MC, Havelka AM, Toi M, Linder S. Olofsson MH, et al. Among authors: ueno t. Clin Cancer Res. 2007 Jun 1;13(11):3198-206. doi: 10.1158/1078-0432.CCR-07-0009. Clin Cancer Res. 2007. PMID: 17545523

4

The aspartic protease napsin A suppresses tumor growth independent of its catalytic activity.

Ueno T, Elmberger G, Weaver TE, Toi M, Linder S. Ueno T, et al. Lab Invest. 2008 Mar;88(3):256-63. doi: 10.1038/labinvest.3700718. Epub 2008 Jan 14. Lab Invest. 2008. PMID: 18195689 Free article.

5

[A case of primary breast cancer who responded remarkably to the neoadjuvant chemotherapy with the combination of docetaxel and cyclophosphamide].

Yoshibayashi H, Ishiguro H, Takada M, Takeuchi M, Yamashiro H, Ueno T, Kato H, Yoshikawa K, Kanao S, Yamauchi C, Mikami Y, Toi M. Yoshibayashi H, et al. Among authors: ueno t. Gan To Kagaku Ryoho. 2008 Jun;35(6):987-90. Gan To Kagaku Ryoho. 2008. PMID: 18633230 Japanese.

6

Adipogenesis induced by human adipose tissue-derived stem cells.

Tsuji W, Inamoto T, Yamashiro H, Ueno T, Kato H, Kimura Y, Tabata Y, Toi M. Tsuji W, et al. Among authors: ueno t. Tissue Eng Part A. 2009 Jan;15(1):83-93. doi: 10.1089/ten.tea.2007.0297. Tissue Eng Part A. 2009. PMID: 18759663 Free article.

7

[Biomarker].

Ueno T, Toi M. Ueno T, et al. Gan To Kagaku Ryoho. 2009 Jan;36(1):15-20. Gan To Kagaku Ryoho. 2009. PMID: 19151560 Japanese.

8

Increased estrogen sulfatase (STS) and 17beta-hydroxysteroid dehydrogenase type 1(17beta-HSD1) following neoadjuvant aromatase inhibitor therapy in breast cancer patients.

Chanplakorn N, Chanplakorn P, Suzuki T, Ono K, Chan MS, Miki Y, Saji S, Ueno T, Toi M, Sasano H. Chanplakorn N, et al. Among authors: ueno t. Breast Cancer Res Treat. 2010 Apr;120(3):639-48. doi: 10.1007/s10549-010-0785-3. Epub 2010 Feb 12. Breast Cancer Res Treat. 2010. PMID: 20151319

9

Clinical significance of the 21-gene signature (Oncotype DX) in hormone receptor-positive early stage primary breast cancer in the Japanese population.

Toi M, Iwata H, Yamanaka T, Masuda N, Ohno S, Nakamura S, Nakayama T, Kashiwaba M, Kamigaki S, Kuroi K; Japan Breast Cancer Research Group-Translational Research Group. Toi M, et al. Cancer. 2010 Jul 1;116(13):3112-8. doi: 10.1002/cncr.25206. Cancer. 2010. PMID: 20564629 Free article.

10

[Vascular endothelial growth factor (VEGF)].

Sakita-Kawaguchi N, Ueno T, Toi M. Sakita-Kawaguchi N, et al. Among authors: ueno t. Nihon Rinsho. 2010 Jul;68 Suppl 7:106-9. Nihon Rinsho. 2010. PMID: 20960757 Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,445 results

Search Page